Journal de pharmacocinétique et thérapeutique expérimentale

Accès libre

Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Abstrait

Pharmacokinetics Modeling: Insights into Drug Absorption, Distribution, Metabolism, and Elimination

Josyion Chiura

Pharmacokinetics modeling plays a vital role in understanding the behavior of drugs within the human body. It involves studying the processes of drug absorption, distribution, metabolism, and elimination to predict their concentration-time profiles and optimize dosing regimens. This paper presents an overview of pharmacokinetics modeling, highlighting its importance in drug development, personalized medicine, and therapeutic optimization.The absorption phase involves the movement of drugs from the site of administration into the bloodstream. Various factors such as drug formulation, route of administration, and physiological barriers influence drug absorption.Pharmacokinetics models aid in quantifying drug absorption rates and predicting bioavailability. The distribution phase characterizes the movement of drugs throughout the body after absorption. Factors like tissue permeability, protein binding, and blood flow rates affect drug distribution. Pharmacokinetics models help estimate drug concentrations in different tissues and compartments, aiding in understanding target site exposure. In conclusion, pharmacokinetics
modeling provides valuable insights into the behavior of drugs within the body. It enables the prediction of drug concentration-time profiles, facilitates personalized medicine approaches, and aids in optimizing dosing regimens for enhanced therapeutic outcomes. Continued advancements in pharmacokinetics modeling techniques will contribute to the development of safer and more effective medications in the future.